Neurona Therapeutics' Series A - II Round

Neurona Therapeutics raised a round of funding on December 28, 2016. Investors include The Column Group.

Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by neuroscientists and stem cell pioneers at The University of California, San Francisco. The company is focused on …

Articles about Neurona Therapeutics' Series A - II Round: